Streetbeat News

Stock Prices

PRFX

PainReform has announced the pricing of a $1.5M registered direct offering of 166,666 shares at $9 per share. The company is also planning a private placement.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:38 pm

AEL

BAM

BNRE

Truist Securities analyst Mark Hughes has downgraded American Equity Investment Life Holding Co (AEL) to Hold from Buy, with an increased price target of $55. Hughes expects AEL's acquisition by Brookfield Reinsurance Ltd (BNRE) to be completed at the current offer price of ~$4.3 billion. AEL shareholders will receive $55.00 per AEL share, consisting of $38.85 in cash and 0.49707 of Brookfield Asset Management Ltd. (BAM) shares. Hughes estimates EPS of $6.30 in 2023 and $6.70 in 2024.

Portfolio Pulse from Lekha Gupta

July 14, 2023 | 6:34 pm

CJET

Chijet Motor Company's majority-owned subsidiary has completed its first shipment of automobile orders to Peru through its newly developed export operation at Tianjin Port, China. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:32 pm

PDD

A significant bullish stance has been taken on PDD Holdings (NASDAQ:PDD) by a large investor or institution, as indicated by a large position in the company's options. The overall sentiment of these big-money traders is split between 54% bullish and 45% bearish. The whales have been targeting a price range from $50.0 to $100.0 for PDD Holdings over the last 3 months. The price of PDD is currently down -2.06% at $79.26.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:32 pm

LULU

A significant investor has taken a bearish stance on Lululemon Athletica (NASDAQ:LULU), with 60% of recent trades being bearish. The price target for LULU over the last 3 months has been between $330.0 and $460.0. Morgan Stanley, Telsey Advisory Group, and Piper Sandler have all downgraded their ratings on LULU, with price targets of $424, $430, and $450 respectively. The current price of LULU is $379.89, up 0.09%.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:32 pm

PCAR

PACCAR (NASDAQ:PCAR) has outperformed the market over the past 5 years, producing an average annual return of 15.18%. If an investor had bought $100 of PCAR stock 5 years ago, it would be worth $204.75 today. The company currently has a market capitalization of $44.63 billion.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:30 pm

ZTS

Zoetis (NYSE:ZTS) has outperformed the market over the past 10 years, producing an average annual return of 18.79%. An investment of $1000 in ZTS stock 10 years ago would be worth $5,566.15 today. The company currently has a market capitalization of $79.71 billion.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 6:30 pm

FRLN

Shares of Freeline Therapeutics have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:29 pm

MRO

Benchmark analyst Subash Chandra has reiterated a Buy rating on Marathon Oil Corporation (MRO), but lowered the price target to $28 from $32 due to declining commodity prices. The analyst expects MRO to generate solid FCF in Q2 2023, with strong production in Delaware. However, the EPS estimate for Q2 has been reduced to $0.44 from $0.55, and the EBITDA forecast has been lowered to $942 million from $978 million due to unfavorable commodity prices. Equity income from Equatorial Guinea is expected to be lower than guidance due to declining oil and LNG prices. MRO shares are currently trading lower by 3.6% to $24.20.

Portfolio Pulse from Nabaparna Bhattacharya

July 14, 2023 | 6:29 pm

FRLN

Freeline Therapeutics' shares have been halted on a circuit breaker to the upside, with the stock now up by 33%.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 6:26 pm